| Evaluation of epithelial lining fluid concentration of amikacin in critically ill patients with ventilator-associated pneumonia F Najmeddin, B Shahrami, S Azadbakht, M Dianatkhah, MR Rouini, ... Journal of intensive care medicine 35 (4), 400-404, 2020 | 34 | 2020 |
| Achievement of vancomycin therapeutic goals in critically ill patients: early individualization may be beneficial B Shahrami, F Najmeddin, S Mousavi, A Ahmadi, MR Rouini, K Sadeghi, ... Critical care research and practice 2016, 2016 | 28 | 2016 |
| Antibiotic therapy in sepsis: No next time for a second chance! B Shahrami, M Sharif, AS Forough, F Najmeddin, AA Arabzadeh, ... Journal of clinical pharmacy and therapeutics, 2021 | 18 | 2021 |
| Evaluation of amikacin pharmacokinetics in critically ill patients with intra-abdominal sepsis B Shahrami, F Najmeddin, MR Rouini, A Najafi, K Sadeghi, S Amini, ... Advanced Pharmaceutical Bulletin 10 (1), 114, 2020 | 10 | 2020 |
| Area under the Curve-Based Dosing of Vancomycin in Critically Ill Patients Using 6-Hour Urine Creatinine Clearance Measurement B Shahrami, F Najmeddin, S Ghaffari, A Najafi, MR Rouini, ... Critical Care Research and Practice 2020, 2020 | 9 | 2020 |
| Remdesivir Administration in COVID-19 Patients With Renal Impairment: A Systematic Review E Davoudi-Monfared, A Ahmadi, E Karimpour-Razkenari, B Shahrami, ... American Journal of Therapeutics, 10.1097, 2022 | 7 | 2022 |
| Identification of drug‐related problems followed by clinical pharmacist interventions in an outpatient pharmacotherapy clinic B Shahrami, A Sefidani Forough, F Najmeddin, E Hadidi, S Toomaj, ... Journal of Clinical Pharmacy and Therapeutics, 2022 | 7 | 2022 |
| Detection of subclinical nephrotoxicity induced by aminoglycosides in critically ill elderly patients using trough levels and urinary neutrophil gelatinase-associated lipocalin K Sadeghi, B Shahrami, FH Fani, H Hamishehkar, M Mojtahedzadeh European Journal of Hospital Pharmacy 29 (e1), e63-e66, 2022 | 6 | 2022 |
| Management of a critically ill patient with COVID-19-related fulminant myocarditis: A case report B Shahrami, E Davoudi-Monfared, Z Rezaie, S Gheibi, A Vakili-Ardabili, ... Respiratory Medicine Case Reports 36, 101611, 2022 | 6 | 2022 |
| Oral substitution of melatonin in critical care: a pharmacokinetic study in patients with intracranial hemorrhage M Rouini, NK Rad, A Najafi, H Sharifnia, M Dianatkhah, M Mojtahedzadeh, ... Journal of Pharmaceutical Care, 2020 | 4 | 2020 |
| A possible guide as a tool to complementary effects of new coronavirus A Sadremomtaz, J Hashemi, A Sahebnasagh, SM Nabavi, ... Archives of Anesthesia and Critical Care, 2021 | 3 | 2021 |
| The controversies surrounding tocilizumab administration following pathogen-associated molecular pattern (PAMP) induced by COVID-19 S Gheibi, F Najmeddin, B Shahrami, K Sadeghi, M Mojtahedzadeh Journal of Pharmaceutical Care, 140-142, 2020 | 3 | 2020 |
| Evaluation of Knowledge, Attitude, and Practice about Rational Prescribing and Use of Drugs among General Practitioners in Tehran City, Iran B Shahrami, M Shahbalaei, A Hamzeh-Zadeh, M Rastegarpanah Journal Of Isfahan Medical School 36 (469), 156-167, 2018 | 3 | 2018 |
| Can intra-abdominal pressure predict the pharmacokinetics of aminoglycosides in critically ill patients with intra-abdominal sepsis? B Shahrami, AA Arabzadeh, F Najmeddin, AS Forough, A Najafi, ... American Journal of Therapeutics 29 (3), e376-e378, 2022 | 2 | 2022 |
| Evaluation of amikacin dosing schedule in critically ill elderly patients with different stages of renal dysfunction S Ghaffari, AM Hadi, F Najmeddin, B Shahrami, MR Rouini, A Najafi, ... European Journal of Hospital Pharmacy 29 (e1), e67-e71, 2022 | 2 | 2022 |
| Therapeutic drug monitoring of vancomycin following critical care illnesses: peak concentration determination maybe critical B Shahrami, F Najmeddin, S Mousavi, A Ahmadi, M Mojtahedzadeh Journal of Pharmaceutical Care, 137-139, 2014 | 2 | 2014 |
| Current and Novel Emerging Medical Therapies for Peripheral Artery Disease: A Literature Review AA Arabzadeh, E Faghfuri, SR Soofiyani, ED Abdolahinia, S Siapush, ... Advanced Pharmaceutical Bulletin 13 (2), 259, 2023 | 1 | 2023 |
| LipoxinA4 as a potential prognostic marker of COVID-19 F Jamali, B Shahrami, A Mojtahedzadeh, F Najmeddin, AA Arabzadeh, ... Journal of Lipids 2022, 2022 | 1 | 2022 |
| Changes of lipoxina4 levels following early hospital management of patients with COVID-19 F Jamali, B Shahrami, F Najmeddin, A Haddadi, M Sharifzadeh, ... Antimicrobial Resistance and Infection Control, 2021 | 1 | 2021 |
| Sepsis-associated cholestasis: the impact of mitochondrial dysfunction (A Case Report) B Noroozi, AM Hadi, B Shahrami, AV Ardabili, F Yoonesi, KH Emami, ... Iraqi National Journal of Medicine 3 (1), 44-48, 2020 | 1 | 2020 |
Dr.Mojtaba MojtahedzadehTehran University Medical Sciences/Sina Hospitalایمیل تأیید شده در sina.tums.ac.ir
